Northwestern
Northwestern
Chicago, Illinois, United States17 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| TVMR With the INNOVALVE System Trial - Early Feasibility Study | cardiovascular disorder, heart disorder, heart valve disorder, mitral valve insufficiency | Recruiting | Not applicable | 2026-09-21 | NCT04919980 | |
| Daratumumab for Chemotherapy-Refractory Minimal Residual Disease in T Cell ALL | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, T-cell acute lymphoblastic leukemia, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 2 | 2026-09-15 | NCT05289687 | |
| Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm, small cell lung carcinoma | Recruiting | Phase 2 | 2026-08-28 | NCT07057791 | |
| The GORE® VIABAHN® FORTEGRA Venous Stent IVC Study | Embolism and Thrombosis, Leg Ulcer, Skin Ulcer, Skin and Connective Tissue Diseases, Varicose Ulcer, Venous Thrombosis, cardiovascular disorder, skin disorder, thrombotic disease, varicose disease, vascular disorder, vein disorder | Active, not recruiting | Not applicable | 2026-08-27 | NCT05409976 | |
| The Electronic Medical Records and GEnomics (eMERGE) Network Genomic Risk Assessment | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, hereditary disease | Active, not recruiting | Not applicable | 2026-08-18 | NCT05277116 | |
| Study of COYA 302 for the Treatment of ALS | Nutritional and Metabolic Diseases, TDP-43 proteinopathy, amyotrophic lateral sclerosis, central nervous system disorder, metabolic disease, motor neuron disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, proteostasis deficiencies, spinal cord disorder | Recruiting | Phase 2 / Phase 3 | 2026-08-06 | NCT07161999 | |
| A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy | B-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, diffuse large B-cell lymphoma, immune system disorder, immunoproliferative disorder, large B-cell lymphoma, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, non-Hodgkin lymphoma | Recruiting | Phase 3 | 2026-08-04 | NCT07188558 | |
| PROACTIVE-HF IDE Trial Heart Failure NYHA Class III | cardiovascular disorder, heart disorder, heart failure | Active, not recruiting | Not applicable | 2026-07-24 | NCT04089059 | |
| The TRICURE EFS Study | cardiovascular disorder, heart disorder, heart valve disorder, tricuspid valve insufficiency | Recruiting | Not applicable | 2026-07-23 | NCT06506942 | |
| Effect of Misoprostol on Fluid Deficit Volume in Hysteroscopic Myomectomy | Fibroid Uterus, Hypovolemia, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, Pathologic Processes, Pathological Conditions, Signs and Symptoms, leiomyoma, myomatous neoplasm, neoplasm | Recruiting | Phase 4 | 2026-06-01 | NCT07286188 | |
| Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate carcinoma, prostate disorder | Recruiting | Not stated | 2026-05-15 | NCT04472338 | |
| CIED Infection Quality Initiative Demonstration Project | Infections | Recruiting | Not applicable | 2026-05-06 | NCT05471973 | |
| A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1) | Blood Protein Disorders, Disease Attributes, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Recurrence, acute myeloid leukemia, bone marrow disorder, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, monoclonal gammopathy, myelodysplastic syndrome, myeloid leukemia, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Recruiting | Phase 1 / Phase 2 | 2026-03-24 | NCT04988555 | |
| ALTA TIPS: A 5-year Longitudinal Observational Study of Patients Undergoing TIPS Placement | Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cirrhosis of liver, liver disorder | Active, not recruiting | Not stated | 2026-02-10 | NCT03973372 | |
| Suture Repair vs Mesh Repair for Incisional Hernia | Hernia, Incisional Hernia, Pathologic Processes, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Postoperative Complications | Recruiting | Not applicable | 2026-01-07 | NCT05599750 | |
| Assessment of the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of NK: SEER-2 | neurotrophic keratopathy | Recruiting | Phase 3 | 2025-12-23 | NCT05555589 | |
| Treatment of Moderate to Severe Refractory Crohn's Disease | Abdominal Pain, Crohn disease, Digestive System Diseases, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder | Recruiting | Phase 1 / Phase 2 | 2025-12-10 | NCT06721962 |